IDECABTAGENUM VICLEUCELUM
Účinná látka · 1 přípravek na trhu
- Mezinárodní název
- IDECABTAGENUM VICLEUCELUM
- Český název
- IDEKABTAGEN VIKLEUCEL
- Anglicky
- IDECABTAGENE VICLEUCEL
Synonyma: HUMAN CULTURE EXPANDED GENETICALLY MODIFIED AUTOLOGOUS T CELLS FOR CELL-BASED GENE THERAPY. CELLS ARE DERIVED FROM ISOLATED BLOOD OF THE PATIENT AND ARE TRANSDUCED WITH NON-REPLICATIVE SELF-INACTIVATING (SIN) HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) BASED LENTIVIRAL VECTOR (LVV) PSEUDOTYPED WITH THE VESICULAR STOMATITIS VIRUS GLYCOPROTEIN G (VSV-G) ENVELOPE PROTEIN, AND ENCODING THE C11D5.3 ANTI-TNF RECEPTOR SUPERFAMILY MEMBER 17 (TNFRSF17, BCMA) SINGLE CHAIN VARIABLE FRAGMENT (SCFV) CD8/4-1BB/CD3ZETA CHIMERIC ANTIGEN RECEPTOR (CAR) UNDER THE TRANSCRIPTIONAL CONTROL OF THE MYELOPROLIFERATIVE SARCOMA VIRUS ENHANCER, NEGATIVE CONTROL REGION DELETED, DL587REV PRIMER-BINDING SITE SUBSTITUTED (MND) PROMOTER. CELLS EXHIBIT ANTI-TUMORAL ACTIVITY IN PATIENTS WITH MULTIPLE MYELOMA. · IDECABTAGEN VICLEUCEL · IDECABTAGENE VICLEUCEL · IDECABTAGENUM VICLEUCELUM · IDEKABTAGEN VIKLEUCEL
- ABECMA 260-500X10^6BUNĚK Infuzní disperze na předpis